business

Brookline Capital raises Kymera stock price target on lupus drug data

Investing.com · Jun 8, 2026, 5:53 PM · Also reported by 4 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Prediction: AMD Stock Will Trade at This Price in 2027 Yahoo Finance Deutsche Bank Raises PT on Delta Air Lines (DAL) Stock Yahoo Finance Loop Capital Initiates Coverage of Synchrony Financial (SYF) Stock Yahoo Finance Morgan Stanley Raises PT on Monster Beverage (MNST) Stock

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Brookline Capital raises Kymera stock price target on lupus drug data

Also covered by

More in business